Antigen-specific tumor vaccines: Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy

Journal of Immunology

Volumn 156, Issue 2, 1996, Pages 700-710

  Zhai, Yifan ^a   Yang, James C ^a   Kawakami, Yutaka ^a   Spiess, Paul ^a   Wadsworth, Samuel C ^b   Cardoza, Lisa M ^b   Couture, Larry A ^b   Smith, Alan E ^b   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR VACCINE; VIRUS DNA; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE DEPLETION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; VACCINATION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ADENOVIRUS E3 PROTEINS; ANIMALS; ANTIGENS, NEOPLASM; BUTYRIC ACID; BUTYRIC ACIDS; CELL LINE; DEFECTIVE VIRUSES; DNA, RECOMBINANT; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HLA-A2 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOTHERAPY, ACTIVE; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; MELANOMA, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VACCINES, SYNTHETIC;

EID: 0030026871     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Rosenberg, S A. 1992. Gene therapy of cancer. Important Adv. Oncol. 17.
2. Rosenberg, S A 1991. Immunotherapy and gene therapy of cancer Cancer Res. 51:5074s.
3. van der Bruggen, P., C. Traversari, P. Chomez, C Lurquin, E. De Plaen, B. Van den Eynde, A Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643.
4. Gaugler, B , B. Van den Eynde, P. van der Bruggen, P. Romero, J. J. Gaforio, E De Plaen, B. Lethe, F Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp. Med. 179:921.
5. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B Lethe, P Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489.
6. Robbins, P. F., M. el-Gamil, Y. Kawakami, E. Stevens, J. R. Yanneili, and S. A. Rosenberg. 1994. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54:3124.
7. Kawakami, Y., S Eliyahu, C. H. Delgado, P F. Robbins, L. Rivoltini, S. L Topalian, T. Miki, and S. A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91:3515
8. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P F. Robbins, L. Rivoltini, J R. Yannelli, E. Appella, and S. A. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med 180: 347.
9. Coulie, P. G., V. Brichard, A. Van Pel, T. Wolfel, J. Schneider, C. Traversari, S. Mattei, E. De Plaen, C. Lurquin, and J. P. Szikora. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas (see comments) J. Exp Med. 180:35.
10. Kawakami, Y., S Eliyahu, C. H Delgado, P. F. Robbins, K. Sakaguchi, E Appella, J. R Yannelli, G. J. Adema, T. Miki, and S. A. Rosenberg 1994. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl Acad. Sci. USA 91:6458.
11. Rich, D P., L A. Couture, L M. Cardoza, V. M. Guiggio, D. Armentano, P. C Espino, K Hehir, M J Welsh, A. E Smith, and R. J. Gregory 1993 Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis Hum. Gene Ther. 4:461.
12. Cox, J H , J. R. Bennink, and J. W Yewdell. 1991. Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation J. Exp. Med. 174:1629.
13. Boshart, M., F. Weber, G. Jahn, K. Dorsch-Hasler, B. Fleckenstein, and W. Schaffner. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521.
14. Kawakami, Y., S. Eliyahu, C. Jennings, K. Sakaguchi, X. Kang, S. Southwood, P. F. Robbins, A. Sette, E. Appella, and S A Rosenberg. 1994. Recognition of multiple epitopes in human melanoma antigen gp100 by tumor infiltrating T-lymphocytes associated with in vivo tumor regression. J Immunol 154:3961.
15. Rivoltini, L , Y Kawakami, K Sakaguchi, S. Southwood, A. Sette, P. F. Robbins, F M. Marincola, M. L. Salgaller, J. R. Yanneili, E. Appella, and S. A Rosenberg 1995. Induction of tumor reactive CTL from peripheral blood and tumor infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 154: 2257.
16. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene Proc Natl. Acad. Sci. USA 91:9461.
17. Burgert, H G . and S. Kvist 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens Cell 41:987
18. Wold, W. S , and L R. Gooding. 1991. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1.
19. Korner, H., U. Fritzsche, and H G. Burgert 1992. Tumor necrosis factor alpha stimulates expression of adenovirus early region 3 proteins: implications for viral persistence. Proc Natl. Acad. Sci USA 89:11857
20. Williams, J. L., J. Garcia, D. Harrich, L Pearson, F. Wu, and R. Gaynor. 1990. Lymphoid specific gene expression of the adenovirus early region 3 promoter is mediated by NF-kappa B binding motifs EMBO J. 9:4435
21. Rawle, F. C. B B. Knowles, R. P. Ricciardi, V. Brahmacheri, P. Duerksen-Hughes, W S Wold, and L. R Gooding. 1991. Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5 E1A is immunodominant in H-2b, but not in H-2d or H-2k mice J. Immunol. 146:3977
22. Gamet, L., D. Daviaud, C. Denis-Pouxviel, C. Remesy, and J. C. Murat. 1992. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29. Int. J. Cancer 52:286.
23. Miller, A. A., E. Kurschel, R. Osieka, and C. G. Schmidt. 1987. Clinical pharmacology of sodium butyrate in patients with acute leukemia Eur. J. Cancer Clin. Oncol. 23:1283.
24. Kwon, B. S., K. K. Kim, R. Halaban, and R. T. Pickard. 1994. Characterization of mouse Pmel 17 gene and Silver locus. Pigment Cell Res 7:394.
25. Kozarsky, K. F., and J. M. Wilson. 1993. Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 3:499.
26. Chengalvala, M. V., B. M. Bhat, R. Bhat, M. D Lubeck, S. Mizutani, A. R. Davis, and P. P. Hung. 1994. Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs. J. Gen. Virol. 75:125.
27. Ragot, T., S. Finerty, P. E. Watkins, M. Perricaudet, and A. J. Morgan. 1993 Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin. J. Gen. Virol. 74:501.
28. Berencsi, K., R. F. Rando, C. deTaisne, E. Paoletti, S. A. Plotkin, and E. Gonczol. 1993. Murine cytotoxic T cell response specific for human cytomegalovirus glycoprotein B (gB) induced by adenovirus and vaccinia virus recombinants expressing gB. J. Gen. Virol. 74:2507.
29. Rosenfeld, M. A., K. Yoshimura, B. C. Trapnell, K. Yoneyama, E. R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L. E. Stier, and L. Stratford-Perricaudet. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143.
30. Crystal, R. G., N. G. McElvaney, M. A. Rosenfeld, C. Chu, A. Mastrangeli, J. G. Hay, S. L. Brody, H. A. Jaffe, N. T. Eissa, and C. Danel. 1994. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8:42.
31. Zabner, J., L. A. Couture, R. J. Gregory, S. M. Graham, A. E. Smith, and M. J. Welsh 1993. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75:207.
32. Yang, Y., F. A. Nunes, K Berencsi, B. E. Furth, E. Gonczol, and I. M. Wilson. 1994. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc Natl. Acad. Sci. USA 91:4407.
33. Yang, Y., H. C. J. Ertl, and J. M. Wilson 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice inffected with El-deleted recombinant adenoviruses. Immunity 1:433.